ReviewDiabetes, obesity & metabolism2017

A review of glucagon-like peptide-1 receptor agonists and their effects on lowering postprandial plasma glucose and cardiovascular outcomes in the treatment of type 2 diabetes mellitus.

David R Owens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.